Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Valamanesh

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Biochemical and Biophysical Research Communications|April 25, 2000
Paradoxical effects of mineralocorticoids on the ion gated sodium channel in embryologically diverse cellsM Mirshahi, N Golestaneh, F Valamanesh, et al.
Biochemical and Biophysical Research Communications|February 13, 2001
Mineralocorticoid receptor-mediated signaling regulates the ion gated sodium channel in vascular endothelial cells and requires an intact cytoskeletonN Golestaneh, C Klein, F Valamanesh, et al.
Experimental Eye Research|May 19, 2016
Changes in aquaporin-4 and Kir4.1 expression in rats with inherited retinal dystrophyS Lassiale, F Valamanesh, C Klein, et al.
International Journal of Toxicology|June 11, 2002
The blockade of mineralocorticoid hormone signaling provokes dramatic teratogenesis in cultured rat embryosM Mirshahi, E Ayani, C Nicolas, et al.
Vascular Pharmacology|April 6, 2004
Aldosterone signaling modifies capillary formation by human bone marrow endothelial cellsW Chen, F Valamanesh, T Mirshahi, et al.
International Journal of Toxicology|August 23, 2003
Mineralocorticoid hormones exert dramatic effects on pluripotent human stem cell progenyM Mirshahi, F Valamanesh, N Golestaneh, et al.
Antisense & Nucleic Acid Drug Development|June 14, 2003
Delivery of antisense oligonucleotide to the cornea by iontophoresisM Berdugo, F Valamanesh, C Andrieu, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 14, 2011
In vivo characterisation of a novel water-soluble Cyclosporine A prodrug for the treatment of dry eye diseaseM Rodriguez-Aller, B Kaufmann, D Guillarme, et al.
Circulation|June 25, 2003
Cyclooxygenase-2 in human and experimental ischemic proliferative retinopathyF Sennlaub, F Valamanesh, A Vazquez-Tello, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Biochemical and Biophysical Research Communications|April 25, 2000
Paradoxical effects of mineralocorticoids on the ion gated sodium channel in embryologically diverse cellsM Mirshahi, N Golestaneh, F Valamanesh, et al.
Biochemical and Biophysical Research Communications|February 13, 2001
Mineralocorticoid receptor-mediated signaling regulates the ion gated sodium channel in vascular endothelial cells and requires an intact cytoskeletonN Golestaneh, C Klein, F Valamanesh, et al.
Experimental Eye Research|May 19, 2016
Changes in aquaporin-4 and Kir4.1 expression in rats with inherited retinal dystrophyS Lassiale, F Valamanesh, C Klein, et al.
International Journal of Toxicology|June 11, 2002
The blockade of mineralocorticoid hormone signaling provokes dramatic teratogenesis in cultured rat embryosM Mirshahi, E Ayani, C Nicolas, et al.
Vascular Pharmacology|April 6, 2004
Aldosterone signaling modifies capillary formation by human bone marrow endothelial cellsW Chen, F Valamanesh, T Mirshahi, et al.
International Journal of Toxicology|August 23, 2003
Mineralocorticoid hormones exert dramatic effects on pluripotent human stem cell progenyM Mirshahi, F Valamanesh, N Golestaneh, et al.
Antisense & Nucleic Acid Drug Development|June 14, 2003
Delivery of antisense oligonucleotide to the cornea by iontophoresisM Berdugo, F Valamanesh, C Andrieu, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 14, 2011
In vivo characterisation of a novel water-soluble Cyclosporine A prodrug for the treatment of dry eye diseaseM Rodriguez-Aller, B Kaufmann, D Guillarme, et al.
Circulation|June 25, 2003
Cyclooxygenase-2 in human and experimental ischemic proliferative retinopathyF Sennlaub, F Valamanesh, A Vazquez-Tello, et al.
Pageof 1